The role of cytokines in aquired middle ear cholesteatoma: Literature review;O papel das citocinas no colesteatoma adquirido da orelha média: Revisão da literatura

Revista Brasileira de Otorrinolaringologia

Volumn 70, Issue 6, 2004, Pages 813-818

  Leal Alves, Adriana ^a,b,c   Quintanilba Ribeiro, Fernando De Andrade ^a,b  

^a Faculdade Cie Medicas S Casa S P   (Brazil)

^b Depto Otorrinolaringologia S C   (Brazil)

^c NONE   (Brazil)

Author keywords

Cholesteatoma; Cytokines; Immunohystochemistry; Middle ear

Indexed keywords

CANCER GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR;

BONE DESTRUCTION; CELL INTERACTION; CHOLESTEATOMA; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; MOLECULAR WEIGHT; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SQUAMOUS EPITHELIUM; WOUND HEALING;

EID: 12244298255     PISSN: 00347299     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-72992004000600018     Document Type: Review

References (27)

1. Gyo K, Sasaki S, Yasuyuki N. Residue of middle ear cholesteatoma after intact wall tympanoplasty: surgical findings at one year. Ann Otol Rhinol Laryngol 1996; 105: 615-9.
2. Lim DJ & Saunders WH. Acquired cholesteatoma; light and electron microscopic observations. Ann Otol 1972; 81: 2-12.
3. Schilling V, Bujia J, Negri B, Schulz P, Kastenbauer E. Immunologically activated cells in aural cholesteatoma. Am J Otolaryngol 1991; 12: 249-53.
4. Pereira CSB. Análise de estudos da expressão das citoqueratinas no colesteatoma adquirido. São Paulo; 1997 (dissertação - mestrado - Faculdade de Ciências Médicas da Santa Casa de São Paulo).
5. Pereira CSB. Imunoexpressào da citoqueratina 16 e do Ki-67 no colesteatoma adquirido. São Paulo 2001 (tese - doutorado - Faculdade de Ciências Médicas da Santa Casa de São Paulo).
6. nd ed. New York: Oxford University Press; 1993.
7. Abbas AK, Lichtman AH, Pober JS. Citocinas. In: Imunologia celular e molecular. 2nd ed. Rio de Janeiro: Revinter; 1998, p. 253-270.
8. Marenda SA & Aufdemorte TB. Localization of cytokines in cholesteatoma tissue. Otolaryngology Head Neck Surg 1995; 112: 359-68.
9. Kim CS, Lee CH, Chung JW, Kim CD. Interleukin-1 alpha interleukin-1 beta and interleukin-8 gene expression in human aural cholesteatomas. Acta Otolaryngol 1996; 116(2): 302-6.
10. Bujia J, Kim C, Boyle D, Hammer C, Firestein G, Kastenbauer E. Quantitative analysis of interleuktn-1-alpha gene expression in middle ear cholesteatoma. Laryngoscope 1996; 106: 217-20.
11. Chung JW & Yoon TH. Different production of interleukin-1α interleukin-1β and interleukin-8 from cholesteatomatous and normal epithelium. Acta Otolaryngol (Stockh.) 1998; 118: 386-91.
12. Akimoto R, Pawankar R, Yagi T, Baba S. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha intercellular adhesion molecule-1 interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec 2000; 62(5): 257-65.
13. Yetiser S, Satar B, Aydin N. Expression of epidermal growth factor tumor necrosis factor-alpha and interleukin-1alpha in chronic otitis media with or without cholesteatoma. Otol Neurotol 2002; 23(5): 647-52.
14. Bujia J, Kim C, Oslos P, Kastenbauer E, Hultner L. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas. Eur Arch Otorhinolaryngol 1996; 253: 152-57.
15. Kato A, Ohashi Y, Masamoto T, Sakamoto H Uekawa M Nakai Y. Interleukin-6 and tumor necrosis factor alpha synthesized by cholesteatoma cells affect mucociliary function in the Eustachian tube. Acta Otolaryngol Suppl. 1998; 538: 90-7.
16. Yan SD & Huang CC. Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro. Ann Otol Rhinol Laryngol 1991, 100: 157-61.
17. Amar MS, Wishahi HF, Zakhary MM. Clinical and biochemical studies of bone destruction in cholesteatoma. J Laryngol Otol 1996; 110(6): 534-9.
18. Sastry KVSSR, Sharma SC, Mann SBS, Ganguly NK, Panda NK. Aural cholesteatoma: role of tumor necrosis factor-alpha in bone destruction. The American Journal of Otology 1999; 20: 158-161.
19. Lang S, Schilling V, Wollenberg B, Mack B, Nerlich A. Localization of transforming growth factor-beta expressing cells and comparison with major extracellular components in aural cholesteatoma. Ann Otol Rhinol Laryngol 1997; 106: 669-73.
20. Sudhoff H, Dazert S, Gonzales A.M, Borkowski G, Park SY, Baird A, Hildmann H, Uyan AF. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol 2000; 21(6): 793-8.
21. Ergün S, Zheng X, Carlsöö B. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma. Am J Otol 1996; 17(3): 393-6.
22. Tanaka Y, Shiwa M, Kojima H, Miyazaki H, Kamide Y, Moriyama H. A study on epidermal proliferation ability in cholesteatoma. Laryngoscope 1998; 108: 537-42.
23. Shiwa M, Kojima H, Moriyama H. Expression of transforming growth factor-alpha (TGF-α) in cholesteatoma. J Laryngol Otol Aug. 1998; 112(8): 750-54.
24. a ed. São Paulo: Guanabara Koogan; 2000. p. 171-97.
25. Bujia J, Kim C, Holly A, Sudhoff H, Oslos P, Kastenbauer E. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression. Am J Otol 1996;17(2): 203-6.
26. Ottaviani F, Neglia C. B, Berti E. Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth? Acta Otolaryngol. (Stockh.) 1999;119: 462-7.
27. Yamamoto-Fukuda T, Aoki D, Hishikawa Y, Kobayashi T, Takahashi H, Koji T. Possible involvement of keratinocyte growth factor and its receptor in enhanced epithelial-cell poliferation and acquired recurrence of middle-ear cholesteatoma. Lab Invest 2003; 83(1): 123-36.